SOURCE: Informa

Informa

June 18, 2014 11:38 ET

Investment in Innovation (IN3) Medical Device 360 Boston Host Large Company Executives, Investors, and Innovators for Strategic Partnering and M & A Discussions

BOSTON, MA--(Marketwired - Jun 18, 2014) -   'Investment in Innovation (IN3) Medical Device 360° Boston,' the medtech industry's leading partnering event being held at Hyatt Regency, will be hosting executives for dealmaking discussions. Several panels focusing on transactions are featured. 

An exciting new session features Creative Deal Structures: Lessons Learned in MedTech Transactions. This session focuses on recent trends in innovative deal structures used for acquiring, financing and monetizing MedTech companies and assets. The panel will review key considerations involving earn-outs and contingent payments, asset-centric corporate structures, and Spin-Offs and Carve-Outs. Session leaders are Richard Smith, Partner, McDermott Will & Emery, LLP and Paul DeStefano, Partner, McDermott Will & Emery, LLP to date.

Several leading large device companies will speak on the topic of "Hospital, Heal Thyself: How Hospital and Insurers are Improving Patient Care and their Bottom Lines through Venture Investment." Issues covered include:

  • Payors and providers are emerging as influential strategic investors
  • Like traditional strategics, these investors can offer unique insights on a rapidly changing market
  • But unlike strategics, these investors can provide first person accounts of what will sell and what won't
  • Find out how you can avoid costly pitfalls and unnecessary expense

Panelists are David Milne, Managing Partner, SV Life Sciences, Ryan Schuler, Managing Director, Ascension Ventures and Ravish Sachar, MD, FACC, Managing Director, Rex Health Ventures.

Several leading large device companies will speak on the topic of "What Acquirers Want to See in a Start-Up Before Buying." Issues covered include:

  • What is your current philosophy/approach to acquisitions in terms of technology development vs. internally-driven R&D?
  • What role does M&A play? What do you believe is the success rate of device M&A deals?
  • Where do large corporations see the greatest opportunity for growth?
  • What questions should start-ups have already answered before approaching a potential buyer?
  • Are there enough venture-backed small companies in the pipeline so that you're satisfied that you're seeing a robust flow of opportunities

Panelists are from Baxter, Phillips, Medtronic, and Johnson & Johnson.

IN3 Medical Device 360° Boston will also feature presentations by 30+ early-, mid- and late-stage start-up companies seeking funding and/or strategic partnership across the spectrum of diagnostic and therapeutic device markets. For a snapshot of companies, please see here.

2014 participating companies already include Fidelity Biosciences, NMT Capital, Catalyst Health Ventures, Siemens, Polaris Venture Partners, GE, Third Rock Ventures, Sofinnova Ventures, Arboretum Ventures, Zeraya Capital, Healthcare Royalty Partners, New Leaf Venture Partners, SV Life Sciences, Ascension Ventures, Nexus Medical & Technology Capital, Fidelity Biosciences, Rex Health Ventures, Baxter, Philips, Medtronic, Johnson & Johnson, MVM Life Sciences, and more.

This two-day special event will benefit a wide variety of participants in the medical device sector: start-ups seeking investment or strategic partnerships, investment firms, VCs, mid-size and large medical device manufacturers, and service providers. The conference also will feature an outstanding agenda of panels, networking sessions and meet-and-greets with industry thought leaders discussing the most pressing issues facing the global device industry in 2014 and beyond. Partnering software will be available to all registered attendees prior to the conference so that one-on-one onsite meetings can be pre-arranged.

Emerging medtech companies that would like to apply to present in Boston should contact Heej Ko at heej.ko@informa.com

Visit www.in3boston.com for full conference and registration details.

About IN3 Medical Device 360° Conferences
Investment-In-Innovation (IN3) Medical Device 360° Conferences have been regarded as one of the most exceptional medical device partnering events for the past 14 years. The conferences highlight early-to late state companies looking to meet and network with potential investors from the healthcare investment firms, to larger top-tier medical device companies for the purpose of funding, M&A, or strategic partnership. International industry experts discuss the most pressing issues during a variety of financing, business development, clinical/regulatory, reimbursement and emerging market panel discussions, presentations and networking sessions.

Contact Information

  • Media Contact:
    Heej Ko
    IN3 Medical Device 360° Conferences
    203-291-9576
    Email Contact